Skip to main content
 

Mediwhale

Mediwhale

Mediwhale is an innovative retina-based AI company that autonomously assesses cardiovascular disease risk. With a simple eye scan using fundus cameras, the company’s AI algorithm analyzes the blood vessels in the retinal images and generates a future cardiovascular disease risk with comparable performance to a heart CT scan within a minute, providing a safe, affordable, and accessible solution at the point of care. Mediwhale also expands the coverage from cardiovascular disease to renal and metabolic diseases.

More News

  • Digital care in your pocket: The role of technology in exercise, fitness, prevention, and rehabilitation

  • The Heart of the Matter: Why Cardiovascular Disease Is Digital Health’s Next Frontier

  • New dietary guidance emphasizes 9 key steps for eating well to support heart health